The research conducted by Kuhlmann et al. and Chebouti et al. has shown that the existence of ERCC1-positive CTCs is linked to the resistance of ovarian cancer to platinum and is also associated with a negative prognosis [262]. Here, ERCC1 is linked to ovarian cancer.